SCHEMBL247635

SCHEMBL247635

O=C(Nc1cn2nc(CCc3nnc4ccc(Br)cn34)ccc2n1)C1CC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 12/20 0.43
CSNK1D P48730 7/20 0.41
CSNK1E P49674 7/20 0.41
MET P08581 1/20 0.39
PDGFRB P09619 2/20 0.38
FLT1 P17948 2/20 0.38
AURKA O14965 1/20 0.38
KIT P10721 1/20 0.38
ABL1 P00519 1/20 0.38
CSF1R P07333 1/20 0.38
YES1 P07947 1/20 0.38
RET P07949 1/20 0.38
BCR P11274 1/20 0.38
PDGFRA P16234 1/20 0.38
FLT4 P35916 1/20 0.38
ABL2 P42684 1/20 0.38
DDR1 Q08345 1/20 0.38
DDR2 Q16832 1/20 0.38
AAK1 Q2M2I8 1/20 0.38
Q6ZSR9 Q6ZSR9 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1551292 0.86 CSNK1D (0.52) KDRCSNK1DCSNK1EMETPDGFRB
SCHEMBL253423 0.78 KDR (0.42) KDRCSNK1DCSNK1EMETBRAF
SCHEMBL5955070 0.78 KDR (0.42) KDRCSNK1DCSNK1EMETPDGFRB
SCHEMBL250805 0.78 KDR (0.43) KDRCSNK1DCSNK1EMETBRAF
SCHEMBL5955206 0.77 KDR (0.43) KDRCSNK1DCSNK1EMETPDGFRB
SCHEMBL5955078 0.77 KDR (0.42) KDRCSNK1DCSNK1EMETBRAF
SCHEMBL5955401 0.77 KDR (0.43) KDRCSNK1DCSNK1EMETBRAF
SCHEMBL247634 0.76 KDR (0.42) KDRCSNK1DCSNK1EMETPDGFRB
SCHEMBL246807 0.76 PIK3CG (0.41) MET
SCHEMBL5954582 0.75 GSK3B (0.48) CSNK1DCSNK1EABL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2588107-A1 COMBINATION OF A cMET INHIBITOR AND AN ANTIBODY TO HGF AND/OR cMET Takeda Pharmaceutical Company Limited (JP) 2013-05-08 EP disclosed
WO-2012003338-A1 COMBINATION OF A cMET INHIBITOR AND AN ANTIBODY TO HGF AND/OR cMET TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2012-01-05 WO disclosed
EP-2313407-A1 cMET INHIBITORS Takeda Pharmaceutical Company Limited (JP) 2011-04-27 EP disclosed
WO-2010019899-A1 cMET INHIBITORS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2010-02-18 WO disclosed